Company: PFSA
Filing Date: 2025-02-12
Form Type: S-4/A
Source: 0001213900-25-012354
Chunk: 74

Company: Profusa, Inc.
Filing Date: 2025-02-12
Form: S-4/A
Chunk 74
---
 |  12.5 |
| Northview working capital loan(9)                                                                 |     |            863,908 |     |   2.6 |     |            863,908 |     |   2.5 |
| PIPE Subscription(6)                                                                              |     |          1,000,000 |     |   3.0 |     |          1,000,000 |     |   3.0 |
| Total shares of New Profusa Common Stock on the expected closing date of the Business Combination |     |         33,589,046 |     | 100.0 |     |         33,323,824 |     | 100.0 |

____________ (1)Assumes redemptions of 265,222 common shares held by NorthView public stockholders subject to possible redemption in connection with the Business Combination at approximately $11.84 per share based on trust account figures as of September 30, 2024. (2)Includes Sponsor and Representative shares in NorthView and has been reduced by the 710,220 sponsor shares allocated to the senior secured convertible note holders. (3)Includes 7,490,686shares expected to be issued to existing Profusa common and preferred shareholders, 7,599,525shares expected to be issued to the holders of Profusa’s junior convertible notes and senior convertible notes, and 409,789shares reserved for Profusa option holders under each redemption scenario. (4)Includes 1,897,500shares issuable pursuant to outstanding NorthView Rights. (5)Represents $1,575,000 of transaction costs being paid in shares of common stock at $10 per share.

10 (6)Assumes 1,000,000shares issuable upon conversion of the $10 million first tranche of the PIPE Investor convertible note facility ($22.22 million total) at $10 per share. (7)Senior secured convertible note which includes 710,220 Sponsor shares that were utilized as inducement shares for the notes. (8)Represents 1,267,255shares issued upon the conversion and exchange of Profusa bridge notes and 2,901,833shares issued in exchange for the shares issued pursuant to the Bridge Note Buyout Agreement. (9)Representation shares from the conversion of the NorthView working capital convertible loan at a $2.22 per share. For more information, see the section entitled “ Unaudited Pro Forma Condensed Combined Financial